Enrique Dilone
Hoofd Techniek/Wetenschap/O&O bij IMMUNITYBIO, INC.
Profiel
Dr. Enrique Dilone is a Chief Technology Officer at ImmunityBio, Inc. He is on the Board of Directors at La Casa de Don Pedro, Inc. Dr. Dilone was previously employed as a Senior Vice President-Technical Operations by Amicus Therapeutics, Inc., an Executive Director-Quality & Analytics by NovaDel Pharma, Inc., a Director-Analytical Operations by Oldtech, Inc., and a Chief Technology Officer by Prothelia, Inc. He received his undergraduate degree from New York University, a graduate degree from Seton Hall University and a doctorate degree from Seton Hall University.
Actieve functies van Enrique Dilone
| Bedrijven | Functie | Begin |
|---|---|---|
| IMMUNITYBIO, INC. | Hoofd Techniek/Wetenschap/O&O | 14-08-2023 |
La Casa de Don Pedro, Inc.
 La Casa de Don Pedro, Inc. Miscellaneous Commercial ServicesCommercial Services La Casa de Don Pedro, Inc. operates as a non-profit-organisation. The firm conducts s, adult and alternative education, immigration and integration, and energy conservation and assistance, and childhood program. The company was founded in 1972 and is headquartered in Newark, NJ. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Enrique Dilone
| Bedrijven | Functie | Einde |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Corporate Officer/Principal | 01-10-2019 |
| NOVADEL PHARMA INC | Corporate Officer/Principal | 01-08-2009 |
Oldtech, Inc.
 Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Corporate Officer/Principal | 01-12-2006 |
Prothelia, Inc.
 Prothelia, Inc. BiotechnologyHealth Technology Prothelia, Inc. operates as a biotechnological company that engages in the provision of protein therapy. It focuses on the treatment of congenital muscular dystrophy type 1A. The company was founded by Bradley Hodges and is headquartered in Milford, MA. | Hoofd Techniek/Wetenschap/O&O | - |
Opleiding van Enrique Dilone
| Seton Hall University | Doctorate Degree |
| New York University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| AMICUS THERAPEUTICS, INC. | Health Technology |
| IMMUNITYBIO, INC. | Health Technology |
| Bedrijven in privébezit | 4 |
|---|---|
NovaDel Pharma, Inc.
 NovaDel Pharma, Inc. Pharmaceuticals: MajorHealth Technology NovaDel Pharma, Inc. engages in developing oral spray formulations for different types of drugs. It develops oral spray and pharmaceutical products for angina pectoris, insomia, migraine headaches, and disorders of the central nervous system. The company was founded in 1982 and is headquartered in Bridgewater, NJ. | Health Technology |
Oldtech, Inc.
Oldtech, Inc. BiotechnologyHealth Technology Oldtech, Inc. was engaged in developing treatments for conditions that affect the back of the eye, including age related macular degeneration (AMD) and diabetic macular edema (DME). The company was headquartered in New York. | Health Technology |
La Casa de Don Pedro, Inc.
La Casa de Don Pedro, Inc. Miscellaneous Commercial ServicesCommercial Services La Casa de Don Pedro, Inc. operates as a non-profit-organisation. The firm conducts s, adult and alternative education, immigration and integration, and energy conservation and assistance, and childhood program. The company was founded in 1972 and is headquartered in Newark, NJ. | Commercial Services |
Prothelia, Inc.
Prothelia, Inc. BiotechnologyHealth Technology Prothelia, Inc. operates as a biotechnological company that engages in the provision of protein therapy. It focuses on the treatment of congenital muscular dystrophy type 1A. The company was founded by Bradley Hodges and is headquartered in Milford, MA. | Health Technology |
